These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31421272)

  • 21. Reducing the dosing frequency of selective digestive tract decontamination to three times daily provides effective decontamination of Gram-negative bacteria.
    de la Court JR; Sigaloff KCE; Groot T; van der Spoel JI; Schade RP
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1843-1850. PubMed ID: 33791891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands.
    Houben AJ; Oostdijk EA; van der Voort PH; Monen JC; Bonten MJ; van der Bij AK;
    J Antimicrob Chemother; 2014 Mar; 69(3):797-804. PubMed ID: 24144922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquisition of carbapenem-resistant Gram-negative bacilli in intensive care unit: predictors and molecular epidemiology.
    Marchenay P; Blasco G; Navellou JC; Leroy J; Cholley P; Talon D; Bertrand X; Gbaguidi-Haore H
    Med Mal Infect; 2015; 45(1-2):34-40. PubMed ID: 25640914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. For whom should we use selective decontamination of the digestive tract?
    de Smet AM; Bonten MJ; Kluytmans JA
    Curr Opin Infect Dis; 2012 Apr; 25(2):211-7. PubMed ID: 22274728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of antibiotic cycling and mixing on acquisition of antibiotic resistant bacteria in the ICU: A post-hoc individual patient analysis of a prospective cluster-randomized crossover study.
    van Duijn PJ; Verbrugghe W; Jorens PG; Spöhr F; Schedler D; Deja M; Rothbart A; Annane D; Lawrence C; Jereb M; Seme K; Šifrer F; Tomič V; Estevez F; Carneiro J; Harbarth S; Bonten MJM
    PLoS One; 2022; 17(5):e0265720. PubMed ID: 35503768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of selective digestive decontamination as a natural experiment to evaluate topical antibiotic prophylaxis and cephalosporin use as population-level risk factors for enterococcal bacteraemia among ICU patients.
    Hurley JC
    J Antimicrob Chemother; 2019 Oct; 74(10):3087-3094. PubMed ID: 31355880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for colonization with multidrug-resistant Gram-negative bacteria and
    Azzini AM; Be G; Naso L; Lambertenghi L; Salerno ND; Coledan I; Bazaj A; Mirandola M; Miotti J; Mazzaferri F; Accordini S; Lo Cascio G; Tacconelli E
    Front Cell Infect Microbiol; 2023; 13():1155320. PubMed ID: 37377644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial.
    de Jonge E; Schultz MJ; Spanjaard L; Bossuyt PM; Vroom MB; Dankert J; Kesecioglu J
    Lancet; 2003 Sep; 362(9389):1011-6. PubMed ID: 14522530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ecological effects of selective decontamination of the digestive tract (SDD) on antimicrobial resistance: a 21-year longitudinal single-centre study.
    Buitinck S; Jansen R; Rijkenberg S; Wester JPJ; Bosman RJ; van der Meer NJM; van der Voort PHJ
    Crit Care; 2019 Jun; 23(1):208. PubMed ID: 31174575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term use of selective digestive decontamination in an ICU highly endemic for bacterial resistance.
    Sánchez-Ramírez C; Hípola-Escalada S; Cabrera-Santana M; Hernández-Viera MA; Caipe-Balcázar L; Saavedra P; Artiles-Campelo F; Sangil-Monroy N; Lübbe-Vázquez CF; Ruiz-Santana S
    Crit Care; 2018 May; 22(1):141. PubMed ID: 29843808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The added value of the selective SuperPolymyxin™ medium in detecting rectal carriage of Gram-negative bacteria with acquired colistin resistance in intensive care unit patients receiving selective digestive decontamination.
    van Hout D; Janssen AB; Rentenaar RJ; Vlooswijk JPM; Boel CHE; Bonten MJM
    Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):265-271. PubMed ID: 31691864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquisition of carbapenem-resistant gram-negative bacilli among intensive care unit (ICU) patients with no previous use of carbapenems: Indirect population impact of antimicrobial use.
    Oliveira JDS; Sampaio NCFM; Leite GS; Pereira MADM; Fortaleza CMCB
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1575-1579. PubMed ID: 35156602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development.
    Liao Q; Feng Z; Lin H; Zhou Y; Lin J; Zhuo H; Chen X
    Front Cell Infect Microbiol; 2023; 13():1109418. PubMed ID: 36794004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission.
    Ho PL;
    Crit Care Med; 2003 Apr; 31(4):1175-82. PubMed ID: 12682490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ICU-CARB score: a novel clinical scoring system to predict carbapenem-resistant gram-negative bacteria carriage in critically ill patients upon ICU admission.
    Dai Y; Zhang L; Pan T; Shen Z; Meng T; Wu J; Gu F; Wang X; Tan R; Qu H
    Antimicrob Resist Infect Control; 2023 Oct; 12(1):118. PubMed ID: 37898771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of systematic screening for AmpC-hyperproducing Enterobacterales intestinal carriage in intensive care unit patients.
    Manquat E; Le Dorze M; Pean De Ponfilly G; Benmansour H; Amarsy R; Cambau E; Soyer B; Chousterman BG; Jacquier H
    Ann Intensive Care; 2020 Oct; 10(1):149. PubMed ID: 33119840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Papas V; Pitsiolis T; Tsakris A; Nanas S; Roussos C
    Intensive Care Med; 2013 Jul; 39(7):1253-61. PubMed ID: 23604133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.
    Maina JW; Mutua JM; Musyoki AM
    BMC Infect Dis; 2024 May; 24(1):522. PubMed ID: 38783175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Selective digestive decontamination in patients under reanimation].
    Quinio B; Albanèse J; Durbec O; Martin C
    Ann Fr Anesth Reanim; 1994; 13(6):826-38. PubMed ID: 7668421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate.
    Massart N; Camus C; Benezit F; Moriconi M; Fillatre P; Le Tulzo Y
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):889-895. PubMed ID: 31898797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.